Back to results
US 2023/0143550 A1Published application
CD8A-Binding Fibronectin Type III Domains
AssigneeJanssen Biotech, Inc.
InventorsRebecca HAWKINS, Steven JACOBS, Manuel SEPULVEDA
Life of this patent
Estimating the term…
Abstract
Fibronectin type III domains (FN3) that specifically bind to CD8A, related polynucleotides capable of encoding CD8A-specific FN3 domains, cells expressing the FN3 domains, as well as associated vectors, and detectably labeled FN3 domains are useful in therapeutic and diagnostic applications.
Claims22
An isolated FN3 domain that specifically binds to a human CD8A protein comprising the amino acid sequence of SEQ ID NO:
- 35.
-10. (canceled)
(canceled)
Dependencies are inferred from the claim text.